Brief: Kintor Pharmaceutical Says YTD 2026 Sales Revenue At RMB34 Million
20/04/2026 17:22
April 20 (Reuters) - Kintor Pharmaceutical Ltd 9939.HK: YTD 2026 SALES REVENUE REACHES RMB34 MILLION Further company coverage: 9939.HK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kintor Pharmaceutical
See all newsBrief: Kintor Pharmaceutical Receives Invention Patent Grant For KT-939 In China
Brief: Kintor Pharmaceutical Says Ming Ming Cheung Resigns As CFO
Brief: Kintor Pharmaceutical Says CEO Via Wholly Owned Co Increases Shareholding By 2.51 Million Shares
Brief: Kintor Pharmaceutical Says YTD 2026 Sales Revenue At RMB34 Million
Brief: Kintor Pharmaceutical Says Pharma's Kx-826 Phase Iii Trial In China Reaches Primary Endpoint